KENNETT SQUARE, Pa., March 08, 2017 -- Genesis HealthCare today announced that George V. Hager, Jr., Chief Executive Officer, and Tom DiVittorio, Chief Financial Officer, are scheduled to host a fireside chat at the Barclays Global Healthcare Conference on Thursday, March 16, 2017 at 9:30 a.m. Eastern Time. The conference is being held at the Loews Miami Beach Hotel in Miami Beach, FL.
A live webcast and replay of the Company’s fireside chat will be available on the Company’s website at www.genesishcc.com/investor-relations.
About Genesis HealthCare
Genesis HealthCare (NYSE:GEN) is a holding company with subsidiaries that, on a combined basis, comprise one of the nation’s largest post-acute care providers with approximately 500 skilled nursing centers and assisted/senior living communities in 34 states nationwide. Genesis subsidiaries also supply rehabilitation and respiratory therapy to approximately 1,700 healthcare providers in 45 states and the District of Columbia. References made in this release to “Genesis,” “the Company,” “we,” “us” and “our” refer to Genesis Healthcare, Inc. and each of its wholly-owned companies. Visit our website at www.genesishcc.com.
Investor Contact: Genesis HealthCare Lori Mayer 610-925-2000


Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 



